Wolverine Asset Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Wolverine Asset Management’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,670	Closed	-$6.2K	–	2047
2023 Q1	$6.2K	Hold	82,670	–	–	﹤0.01%	1515
2022 Q4	$421	Hold	82,670	–	–	﹤0.01%	2005
2022 Q3	$6K	Hold	82,670	–	–	﹤0.01%	2131
2022 Q2	$9K	Hold	82,670	–	–	﹤0.01%	2025
2022 Q1	$28K	Sell	82,670 -72,030	-47%	-$29.2K	﹤0.01%	1694
2021 Q4	$88K	Buy	+154,700	New	+$79.4K	﹤0.01%	1395

Wolverine Asset Management's LVACW Position: Q2 2023 in Review

Wolverine Asset Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 82,670 shares — an estimated $6.2K sold.

Wolverine Asset Management first reported a position in LVACW in Q4 2021 and held it in 6 quarters. The position peaked at $88K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Wolverine Asset Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 82,670 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $6.2K.
Wolverine Asset Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 6 quarters.
Wolverine Asset Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $88K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.